Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Blood (2015) 126 (6): 746–756.

https://doi.org/10.1182/blood-2015-03-636548

Published: 2015

Includes: Supplemental data

Journal Articles

A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia

Dong Hwan (Dennis) Kim, Seung-Tae Lee, Hong-Hee Won, Seonwoo Kim, Min-Ji Kim, Hee-Jin Kim, Sun-Hee Kim, Jong-Won Kim, Hyeoung-Joon Kim, Yeo-Kyeoung Kim, Sang Kyun Sohn, Joon Ho Moon, Chul Won Jung, Jeffrey H. Lipton

Blood (2011) 117 (25): 6906–6911.

https://doi.org/10.1182/blood-2011-01-329797

Published: 2011

Includes: Supplemental data

Journal Articles

Secondary Acute Myeloid Leukemia (AML), Including Therapy-Related AML, Associates with Worse Treatment Outcomes, Than De Novo AML Even After Hematopoietic Stem Cell Transplantation, and Its Unfavorable Behavior Does Not Associated with Functional Activity of p-Glycoprotein, MDR1

Boram Han, Ha Yeon Lee, Jun Ho Yi, Jun Ho Jang, Kihyun Kim, Hee Jin Kim, Sun-Hee Kim, Chul Won Jung, Dong Hwan (Dennis) Kim

Blood (2010) 116 (21): 2157.

https://doi.org/10.1182/blood.V116.21.2157.2157

Published: 2010

Journal Articles

Multicenter Retrospective Study on the Development of Peripheral Lymphocytosis During Second-Line Dasatinib Therapy for Chronic Myeloid Leukemia

Ha Yeon Lee, Su Jin Lee, Boram Ha, Jun Ho Yi, Chul Won Jung, Dae-Young Kim, Je-Hwan Lee, Kyoo Hyung Lee, Sang Kyun Sohn, Sung Hyun Kim, Won-Sik Lee, Joon Seong Park, Ho-Young Yhim, Jae-Yong Kwak, Hyeoung Joon Kim, MD, PhD, Yeo-Kyeoung Kim, Inho Kim, Seonyang Park, Dong Hwan (Dennis) Kim

Blood (2010) 116 (21): 2275.

https://doi.org/10.1182/blood.V116.21.2275.2275

Published: 2010

Journal Articles

Addition of Hemoglobin Level Into the Prognostic Scoring System Together with White Blood Cell and Platelet Count Provides Better Prognostic Stratification for Treatment-Related Mortality and Overall Survival, but Not for Relapse Risk In Adult Patients with Acute Promyelocytic Leukemia

Jun Ho Yi, Chul Won Jung, Boram Han, Ha Yeon Lee, Jun Ho Jang, Kihyun Kim, Hyeoung Joon Kim, MD, PhD, Yeo-Kyeoung Kim, Won-Sik Lee, Young-Don Joo, Min Kyoung Kim, Myung Soo Hyun, Hawk Kim, Jae Hoo Park, Dong Hwan (Dennis) Kim

Blood (2010) 116 (21): 4371.

https://doi.org/10.1182/blood.V116.21.4371.4371

Published: 2010

Journal Articles

Dasatinib for Chronic Phase Chronic Myeloid Leukemia After Failure of Imatinib In Korean Patients.

Ha Yeon Lee, Myung-Hee Chang, Chul Won Jung, Dong Hwan (Dennis) Kim, Won Seog Kim, Seok Jin Kim, MD, PhD, Kihyun Kim, MD, Jun Ho Jang, Sung-Soo Yoon, Kyoo-Hyung Lee, M.D., PhD., Hyeoung Joon Kim, MD, PhD, Joo-Seop Chung, MD, Sang Kyun Sohn

Blood (2010) 116 (21): 4494.

https://doi.org/10.1182/blood.V116.21.4494.4494

Published: 2010

Journal Articles

Genome-Wide Single-Nucleotide Polymorphism-Array Based Karyotyping Detects Clonal Aberrations, and Predicts the Risk of Imatinib Failure In Chronic Myeloid Leukemia.

Boram Han, Jungwon Huh, Jun Ho Yi, Ha Yeon Lee, Jong-Won Kim, Hee-Jin Kim, Yeo-Kyeoung Kim, Hyeoung Joon Kim, MD, PhD, Joon Ho Moon, Sang Kyun Sohn, Chul Won Jung, Dong Hwan (Dennis) Kim

Blood (2010) 116 (21): 3387.

https://doi.org/10.1182/blood.V116.21.3387.3387

Published: 2010

Journal Articles

Genome-Wide Single-Nucleotide Polymorphism-Array Based Karyotyping Detects Clonal Aberrations Including Uniparental Disomy (UPD), Gain or Loss Which Were Unfavorable Prognostic Factor In Acute Myeloid Leukemia with Normal Karyotype.

Dong Hwan (Dennis) Kim, Jungwon Huh, Boram Han, Ha Yeon Lee, Jun Ho Yi, Jun Ho Jang, Kihyun Kim, Hyeoung Joon Kim, MD, PhD, Yeo-Kyeoung Kim, Sang Kyun Sohn, Joon Ho Moon, Sung Hyun Kim, Chul Won Jung

Blood (2010) 116 (21): 1669.

https://doi.org/10.1182/blood.V116.21.1669.1669

Published: 2010

Journal Articles

A 2-Year Single Center Experience of Decitabine Treatment for the Patients with MDS and CMML

Jun Ho Yi, Chul Won Jung, Dong Hwan (Dennis) Kim, Kihyun Kim, MD, Jun Ho Jang

Blood (2010) 116 (21): 4952.

https://doi.org/10.1182/blood.V116.21.4952.4952

Published: 2010

Journal Articles

Pharmacogenomics-Based Drug Response Prediction Model for Acute Myeloid Leukemia with Normal Karyotype

Dong Hwan (Dennis) Kim, Boram Han, Kyusang Lee, TaeJin Ahn, Dae-soon Son, Insuk Sohn, Sin-Ho Jung, Kyunghee Park, Jun Ho Jang, Kihyun Kim, Hyeoung Joon Kim, MD, PhD, Sang Kyun Sohn, Joon Ho Moon, Jhingook Kim, Nam Huh, Chul Won Jung

Blood (2010) 116 (21): 2698.

https://doi.org/10.1182/blood.V116.21.2698.2698

Published: 2010

Journal Articles

Comprehensive Evaluation of Time-to-Response Parameter as a Predictor of Long-Term Outcomes Following Imatinib Therapy in Chronic Phase Chronic Myeloid Leukemia.

Dong Hwan (Dennis) Kim, Jung A. Kim, Jina Yun, Lakshmi Sriharsha, Jun Ho Jang, Kihyun Kim, Chul Won Jung, Suzanne Kamel-Reid, Jerald Radich, Jeffrey H. Lipton

Blood (2009) 114 (22): 1110.

https://doi.org/10.1182/blood.V114.22.1110.1110

Published: 2009

Journal Articles

Expansion of Large Granular Lymphocytes Following Allogeneic Stem Cell Transplantation: Its Association with Graft-Versus-Host Disease and Graft-Versus-Leukemia Effect.

Dong Hwan (Dennis) Kim, Ghuzayel Al-Dawsari, Chul Won Jung, Chang Hong, Suzanne Kamel-Reid, Janice Wright, Ahmed Galal, Vikas Gupta, John Kuruvilla, Jeffrey H. Lipton, Hans A. Messner

Blood (2009) 114 (22): 2253.

https://doi.org/10.1182/blood.V114.22.2253.2253

Published: 2009

Journal Articles

IFN-γ (interferon-gamma) Genotype Predict Cytogenetic and Molecular Response to Imatinib Therapy in Chronic Myeloid Leukemia.

Dong Hwan Dennis Kim, Jee Hyun Kong, Silvia Park, Chul Won Jung, Lakshmi Sriharsha, Wei Xu, Suzanne Kamel-Reid, Yeo-Kyeoung Kim, Hyeoung-Joon Kim, Jeffrey H. Lipton

Blood (2009) 114 (22): 2178.

https://doi.org/10.1182/blood.V114.22.2178.2178

Published: 2009

Journal Articles

Single Nucleotide Polymorphism (SNP) Approach of Multiple Candidate Pathways Predicting the Risk of Acute / Chronic Graft-Versus-Host Disease or Transplant Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: Potential Involvement of Nuclear Factor Kappa-B (NFKB), Platelet-Derived Growth Factor (PDGF) and Transforming Growth Factor-Beta (TGF-β) Pathway with Chronic Graft-Versus-Host Disease Graft-Versus-Host Disease.

Dong Hwan (Dennis) Kim, Jina Yun, Jee Hyun Kong, Chul Won Jung, Ahmed Galal, Vikas Gupta, John Kuruvilla, Hans A. Messner, Jeffrey H. Lipton

Blood (2009) 114 (22): 2221.

https://doi.org/10.1182/blood.V114.22.2221.2221

Published: 2009

Journal Articles

Effectiveness of Decitabine in Chronic Myelomonocytic Leukemia Patients. International Cooperative Multi-Center Study.

Marcelo Iastrebner, MD, Jun Ho Jang, Isolda Fernandez, Kihyun Kim, M.D., Guy Garay, Dong Hwan (Dennis) Kim, Silvia Saba, Chul Won Jung, Fernando Santini, MD, Haydee i Bernard, MD, Lino Salvatierra, MD, Jorge Korin, MD, Gustavo Taborda, Ricardo Antonio Giuliani, MD, Gabriela Flores, Alejandro Flores, MD

Blood (2009) 114 (22): 3809.

https://doi.org/10.1182/blood.V114.22.3809.3809

Published: 2009

Journal Articles

Validation of Updated Cytogenetic Risk Classification in Patients with Myelodysplastic Syndrome: Retrospective Study at Single Institution.

Jina Yun, Jee Hyun Kong, Jung A. Kim, Dong Hwan Dennis Kim, Jun Ho Jang, Kihyun Kim, Chul Won Jung

Blood (2009) 114 (22): 4837.

https://doi.org/10.1182/blood.V114.22.4837.4837

Published: 2009

Journal Articles

Multicenter Retrospective Analysis of High Dose Chemotherapy and Autologous PBSCT for Ovarian Cancer.

Kyoung Ha Kim, M.D., Jong-Ho Won, M.D., Ph.D., Hee-Sook Park, Seong Hyun Jeong, Hyun Woo Lee, M., D., Joon Seong Park, Seok-Goo Cho, Joon Mo Lee, Chong Won Park, Dong Hwan (Dennis) Kim, Jun Ho Jang, Won Sik Lee, Jung Lim Lee, Yeung-Chul Mun, Chu-Myong Seong, Han Jo Kim

Blood (2009) 114 (22): 4365.

https://doi.org/10.1182/blood.V114.22.4365.4365

Published: 2009

Journal Articles

Multicenter Retrospective Analysis of Second Allogeneic HSCT Outcomes for Hematologic Malignancies in Korea.

Blood (2009) 114 (22): 4298.

https://doi.org/10.1182/blood.V114.22.4298.4298

Published: 2009

Journal Articles

Decitabine Activity in Myelodysplastic Syndromes. International Cooperative Multi-Center Study.

Marcelo Iastrebner, MD, Jun Ho Jang, Elsa Nucifora, MD, Kihyun Kim, M.D., Federico Sackmann, Dong Hwan (Dennis) Kim, Sergio Orlando, Chul Won Jung, Ana Basquiera, MD, Raquel Bengio, Luis Quiroga, MD, Graciela Klein, MD, Juan Garcia, MD, Jorge Arbelbide, Astrid Pavlovsky, Maria Virginia Prates

Blood (2009) 114 (22): 3804.

https://doi.org/10.1182/blood.V114.22.3804.3804

Published: 2009

Journal Articles

Monosomy Karyotype in Acute Myeloid Leukemia Predicts Adverse Treatment Outcome with Low Complete Remission Rate and Worse Event-Free and Overall Survival, and Associates with High Functional Activity of Multidrug Resistance (MDR).

Hee Kyung Ahn, Dong Hwan (Dennis) Kim, Silvia Park, Jun Ho Jang, Kihyun Kim, Hee-Jin Kim, Sun-Hee Kim, Chul Won Jung

Blood (2009) 114 (22): 3112.

https://doi.org/10.1182/blood.V114.22.3112.3112

Published: 2009

NARROW

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia

Secondary Acute Myeloid Leukemia (AML), Including Therapy-Related AML, Associates with Worse Treatment Outcomes, Than De Novo AML Even After Hematopoietic Stem Cell Transplantation, and Its Unfavorable Behavior Does Not Associated with Functional Activity of p-Glycoprotein, MDR1

Multicenter Retrospective Study on the Development of Peripheral Lymphocytosis During Second-Line Dasatinib Therapy for Chronic Myeloid Leukemia

Addition of Hemoglobin Level Into the Prognostic Scoring System Together with White Blood Cell and Platelet Count Provides Better Prognostic Stratification for Treatment-Related Mortality and Overall Survival, but Not for Relapse Risk In Adult Patients with Acute Promyelocytic Leukemia

Dasatinib for Chronic Phase Chronic Myeloid Leukemia After Failure of Imatinib In Korean Patients.

Genome-Wide Single-Nucleotide Polymorphism-Array Based Karyotyping Detects Clonal Aberrations, and Predicts the Risk of Imatinib Failure In Chronic Myeloid Leukemia.

Genome-Wide Single-Nucleotide Polymorphism-Array Based Karyotyping Detects Clonal Aberrations Including Uniparental Disomy (UPD), Gain or Loss Which Were Unfavorable Prognostic Factor In Acute Myeloid Leukemia with Normal Karyotype.

A 2-Year Single Center Experience of Decitabine Treatment for the Patients with MDS and CMML

Pharmacogenomics-Based Drug Response Prediction Model for Acute Myeloid Leukemia with Normal Karyotype

Comprehensive Evaluation of Time-to-Response Parameter as a Predictor of Long-Term Outcomes Following Imatinib Therapy in Chronic Phase Chronic Myeloid Leukemia.

Expansion of Large Granular Lymphocytes Following Allogeneic Stem Cell Transplantation: Its Association with Graft-Versus-Host Disease and Graft-Versus-Leukemia Effect.

IFN-γ (interferon-gamma) Genotype Predict Cytogenetic and Molecular Response to Imatinib Therapy in Chronic Myeloid Leukemia.

Effectiveness of Decitabine in Chronic Myelomonocytic Leukemia Patients. International Cooperative Multi-Center Study.

Validation of Updated Cytogenetic Risk Classification in Patients with Myelodysplastic Syndrome: Retrospective Study at Single Institution.

Multicenter Retrospective Analysis of High Dose Chemotherapy and Autologous PBSCT for Ovarian Cancer.

Multicenter Retrospective Analysis of Second Allogeneic HSCT Outcomes for Hematologic Malignancies in Korea.

Decitabine Activity in Myelodysplastic Syndromes. International Cooperative Multi-Center Study.

Monosomy Karyotype in Acute Myeloid Leukemia Predicts Adverse Treatment Outcome with Low Complete Remission Rate and Worse Event-Free and Overall Survival, and Associates with High Functional Activity of Multidrug Resistance (MDR).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only